Trial · NCT02227264
Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
NCT02227264, Not applicable, Completed, Karolinska University Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions? Trials, record NCT02227264. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02227264
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
- NCT number
- NCT02227264
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 110 participants, actual
- Lead sponsor
- Karolinska University Hospital
- Conditions
- Primary Hyperparathyroidism
- Interventions
- Cinacalcet, parathyroid adenomectomy
- First posted
- 2014-08-28
- Last updated
- 2024-08-06
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Predictive outcome in Quality of Life after parathyroidectomy | after four weeks of calcimimetic treatment and postoperatively | Health related quality of life measured by EORTC QLQ-C30 (total score) |
| Secondary | Psychological well-being | After four weeks of calcimimetic treatment and postoperatively | Psychological well-being, evaluated with the validated form Positive States of Mind, PSOM |
| Secondary | Anxiety and depression | After four weeks of calcimimetic treatment and postoperatively | Depression and anxiety; evaluated with the Hospital Anxiety and Depression (HAD) scale |
| Secondary | Muscle strength | After four weeks of calcimimetic treatment and postoperatively | Leg muscle strength measured by Timed stand-test (repeated uprise from chair) |
| Secondary | Biochemical data | After four weeks of calcimimetic treatment and postoperatively | AE/SAE recording and safety blood samples; serum levels of p-PTH, s-ionized calcium, p-total calcium, p-albumin, p-creatinine, p-phosphate, s-25-OH-D and thyroid-stimulating hormone (TSH) |
| Secondary | Cognitive function | after four weeks of calcimimetic treatment and postoperatively | Cognitive function evaluated with Montreal cognitive assessment (MoCA-test) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 31595982 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02227264
GET https://conductscience.org/api/trials/v1/NCT02227264/registered